{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T01:29:22Z","timestamp":1777426162905,"version":"3.51.4"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Non-alcoholic fatty liver disease is the most common chronic hepatic disease worldwide. Dietary fatty acid is tightly associated with the development of non-alcoholic fatty liver disease but few large-scale and in-depth clinical researches have focused on the issue.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We conducted a retrospective case-control study based on the data from the 2017\u20132018 cycle of the National Health and Nutrition Examination Survey.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 2,470 adult participants were included in this study. Logistic regression analysis showed that dietary fatty acids were positively associated with non-alcoholic fatty liver disease (odds ratio and 95% confidence interval &amp;gt;1 and <jats:italic>P<\/jats:italic> &amp;lt; 0.05) except for polyunsaturated fatty acid. Subgroup analysis stratified by age stage and weight grade revealed that aforementioned association was significant only in individuals aged group 37\u201355 and those classified as obesity. In addition, all the fatty acid related ratios (the ratio of unsaturated fatty acids to saturated fatty acids, the ratio of polyunsaturated fatty acid to saturated fatty acid, the ratio of monounsaturated fatty acids to saturated fatty acids, the ratio of polyunsaturated fatty acids to monounsaturated fatty acids) showed protective effects against the onset and steatosis severity of non-alcoholic fatty liver disease in men, as evidenced by stratified logistic regression analysis (all the odds ratio [95% confidence interval] &amp;lt; 1 and <jats:italic>P<\/jats:italic> &amp;lt; 0.05) and smooth curve fittings.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>These findings suggest that dietary fatty acids modification could serve as a preventive strategy for male non-alcoholic fatty liver disease. Increasing the proportion of unsaturated fatty acids in the diet, especially polyunsaturated fatty acids, is promising to prevent non-alcoholic fatty liver disease in middle-aged obese men.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fnut.2025.1582527","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:06:22Z","timestamp":1751465182000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Sex-specific effect of dietary fatty acids on non-alcoholic fatty liver disease"],"prefix":"10.3389","volume":"12","author":[{"given":"Jianhua","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuning","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiejun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radic Biol Med."},{"key":"B2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1146\/annurev-nutr-071812-161230","article-title":"Omega-3 fatty acids, hepatic lipid metabolism, and nonalcoholic fatty liver disease","volume":"33","author":"Scorletti","year":"2013","journal-title":"Annu Rev Nutr."},{"key":"B3","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1097\/MCO.0000000000000865","article-title":"Polyunsaturated fatty acids and metabolic health: novel insights","volume":"25","author":"Djuricic","year":"2022","journal-title":"Curr Opin Clin Nutr Metab Care."},{"key":"B4","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1038\/s41575-021-00472-y","article-title":"Dietary carbohydrates and fats in nonalcoholic fatty liver disease","volume":"18","author":"Yki-J\u00e4rvinen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"872","DOI":"10.3390\/nu11040872","article-title":"Oxidative stress and non-alcoholic fatty liver disease: effects of omega-3 fatty acid supplementation","volume":"11","author":"Yang","year":"2019","journal-title":"Nutrients."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.3390\/nu13051442","article-title":"Overview of non-alcoholic fatty liver disease (NAFLD) and the role of sugary food consumption and other dietary components in its development","volume":"13","author":"Vancells Lujan","year":"2021","journal-title":"Nutrients."},{"key":"B7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/MOG.0b013e3283358a58","article-title":"Implications of diet on nonalcoholic fatty liver disease","volume":"26","author":"Sullivan","year":"2010","journal-title":"Curr Opin Gastroenterol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1172\/JCI92407","article-title":"Out of the frying pan: dietary saturated fat influences nonalcoholic fatty liver disease","volume":"127","author":"Parks","year":"2017","journal-title":"J Clin Invest."},{"key":"B9","doi-asserted-by":"publisher","first-page":"C630","DOI":"10.1152\/ajpcell.00123.2022","article-title":"Role of hepatic lipid species in the progression of nonalcoholic fatty liver disease","volume":"323","author":"Deng","year":"2022","journal-title":"Am J Physiol-Cell Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.clnesp.2023.06.027","article-title":"Effect of fish oil supplementation on the concentration of miRNA-122, FGF-21 and liver fibrosis in patients with NAFLD: Study protocol for a randomized, double-blind and placebo-controlled clinical trial","volume":"57","author":"Barroso","year":"2023","journal-title":"Clin Nutr ESPEN."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1002\/hep4.1906","article-title":"Effect of omega-3 polyunsaturated fatty acids on lipid metabolism in patients with metabolic syndrome and NAFLD","volume":"6","author":"\u0160m\u00edd","year":"2022","journal-title":"Hepatol Commun."},{"key":"B12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clnu.2017.01.006","article-title":"Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids","volume":"37","author":"de Castro","year":"2018","journal-title":"Clin Nutr."},{"key":"B13","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-nutr-061021-030223","article-title":"Nonalcoholic fatty liver disease and omega-3 fatty acids: mechanisms and clinical use","volume":"43","author":"Spooner","year":"2023","journal-title":"Annu Rev Nutr."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.3390\/nu10091326","article-title":"Soybean oil-derived poly-unsaturated fatty acids enhance liver damage in NAFLD induced by dietary cholesterol","volume":"10","author":"Henkel","year":"2018","journal-title":"Nutrients."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocrine Pract."},{"key":"B16","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.2337\/dc18-S002","article-title":"2. Classification and diagnosis of diabetes:standards of medical care in diabetes\u20132018","volume":"41","year":"2017","journal-title":"Diabetes Care."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension."},{"key":"B18","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2017","journal-title":"Hepatology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1053\/j.gastro.2019.01.042","article-title":"Accuracy of fibroscan controlled attenuation parameter and liver stiffness measurement in assessing steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"156","author":"Eddowes","year":"2019","journal-title":"Gastroenterology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1097\/HEP.0000000000000323","article-title":"AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease","volume":"77","author":"Rinella","year":"2023","journal-title":"Hepatology."},{"key":"B21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.35434\/rcmhnaaa.2020.132.675","article-title":"Metodolog\u00edas Cuantitativas 2: Sesgo de confusi\u00f3n y c\u00f3mo controlar un confusor","volume":"13","author":"Quispe","year":"2020","journal-title":"Revista Del Cuerpo M\u00e9dico Del HNAAA."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1148417","DOI":"10.3389\/fendo.2023.1148417","article-title":"Gender-specific effects of oxidative balance score on the prevalence of diabetes in the US population from NHANES","volume":"14","author":"Wu","year":"2023","journal-title":"Front Endocrinol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/biof.135","article-title":"Fatty acids and the endoplasmic reticulum in nonalcoholic fatty liver disease","volume":"37","author":"Gentile","year":"2010","journal-title":"BioFactors."},{"key":"B24","doi-asserted-by":"publisher","first-page":"107127","DOI":"10.1016\/j.isci.2023.107127","article-title":"Large-scale metabolomic profiling and incident non-alcoholic fatty liver disease","volume":"26","author":"Gagnon","year":"2023","journal-title":"IScience."},{"key":"B25","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.3390\/nu15143200","article-title":"Comparison of the effects of monounsaturated fatty acids and polyunsaturated fatty acids on liver lipid disorders in obese mice","volume":"15","author":"Liu","year":"2023","journal-title":"Nutrients."},{"key":"B26","doi-asserted-by":"publisher","first-page":"1549","DOI":"10.3390\/biomedicines9111549","article-title":"Sex-dependent effects of eicosapentaenoic acid on hepatic steatosis in UCP1 knockout mice","volume":"9","author":"Albracht-Schulte","year":"2021","journal-title":"Biomedicines."},{"key":"B27","doi-asserted-by":"publisher","first-page":"191","DOI":"10.2217\/17455057.5.2.191","article-title":"Nonalcoholic fatty liver disease in women","volume":"5","author":"Suzuki","year":"2009","journal-title":"Women's Health."},{"key":"B28","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1471-230X-12-69","article-title":"A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease","volume":"12","author":"Kim","year":"2012","journal-title":"BMC Gastroenterol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1089\/jwh.2018.7263","article-title":"Serum testosterone level within normal range is positively associated with nonalcoholic fatty liver disease in premenopausal but not postmenopausal women","volume":"28","author":"Park","year":"2019","journal-title":"J Women's Health."},{"key":"B30","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1053\/j.gastro.2016.09.017","article-title":"Estrogen signals through peroxisome proliferator-activated receptor\u2013\u03b3 coactivator 1\u03b1 to reduce oxidative damage associated with diet-induced fatty liver disease","volume":"152","author":"Besse-Patin","year":"2017","journal-title":"Gastroenterology."},{"key":"B31","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jnutbio.2007.10.001","article-title":"The role of fatty acids in the development and progression of nonalcoholic fatty liver disease","volume":"19","author":"Gentile","year":"2008","journal-title":"J Nutr Biochem."},{"key":"B32","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12937-016-0191-8","article-title":"Role of bioactive fatty acids in nonalcoholic fatty liver disease","volume":"15","author":"Ju\u00e1rez-Hern\u00e1ndez","year":"2015","journal-title":"Nutr J."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1117626","DOI":"10.3389\/fnut.2023.1117626","article-title":"Associations between dietary fatty acid patterns and non-alcoholic fatty liver disease in typical dietary population: a UK biobank study","volume":"10","author":"Tian","year":"2023","journal-title":"Front Nutr."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1002\/hep.30626","article-title":"Sex differences in nonalcoholic fatty liver disease: state of the art and identification of research gaps","volume":"70","author":"Lonardo","year":"2019","journal-title":"Hepatology."},{"key":"B35","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.1096\/fj.202000194R","article-title":"Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model","volume":"34","author":"Conti","year":"2020","journal-title":"FASEB J."},{"key":"B36","doi-asserted-by":"publisher","first-page":"e13236","DOI":"10.1111\/eci.13236","article-title":"Macrophages in the pathophysiology of NAFLD: The role of sex differences","volume":"50","author":"Ministrini","year":"2020","journal-title":"Eur J Clin Invest."},{"key":"B37","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology."},{"key":"B38","doi-asserted-by":"publisher","first-page":"100308","DOI":"10.1016\/j.labinv.2023.100308","article-title":"NLRP3 deficiency in nonimmune cells averts obesity-induced fatty liver disease","volume":"104","author":"Margalit Grigg","year":"2024","journal-title":"Laboratory Investigation."}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1582527\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T14:06:23Z","timestamp":1751465183000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2025.1582527\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":38,"alternative-id":["10.3389\/fnut.2025.1582527"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2025.1582527","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"article-number":"1582527"}}